within Pharmacolibrary.Drugs.ATC.D;

model D06BB03
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 0.004333333333333333,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00067,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.014,
    Tlag           = 0,            
    Vdp             = 0.00053,
    k12             = 0.26,
    k21             = 0.26
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D06BB03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Aciclovir is an antiviral medication primarily used for the treatment of infections caused by herpes simplex virus and varicella zoster virus, including genital herpes, cold sores, shingles, and chickenpox. It is available under prescription and remains an approved and commonly used antiviral drug globally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral dose of 400 mg aciclovir.</p><h4>References</h4><ol><li><p>Leung, AKC, &amp; Barankin, B (2017). Herpes Labialis: An Update. <i>Recent patents on inflammation &amp; allergy drug discovery</i> 11(2) 107–113. DOI:<a href=&quot;https://doi.org/10.2174/1872213X11666171003151717&quot;>10.2174/1872213X11666171003151717</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28971780/&quot;>https://pubmed.ncbi.nlm.nih.gov/28971780</a></p></li><li><p>Gnann, JW, et al., &amp; Whitley, RJ (1983). Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. <i>Pharmacotherapy</i> 3(5) 275–283. DOI:<a href=&quot;https://doi.org/10.1002/j.1875-9114.1983.tb03274.x&quot;>10.1002/j.1875-9114.1983.tb03274.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6359082/&quot;>https://pubmed.ncbi.nlm.nih.gov/6359082</a></p></li><li><p>MacDougall, C, &amp; Guglielmo, BJ (2004). Pharmacokinetics of valaciclovir. <i>The Journal of antimicrobial chemotherapy</i> 53(6) 899–901. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkh244&quot;>10.1093/jac/dkh244</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15140857/&quot;>https://pubmed.ncbi.nlm.nih.gov/15140857</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D06BB03;
